Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$11.27 - $13.53 $140,300 - $168,434
-12,449 Reduced 6.07%
192,614 $2.3 Million
Q4 2023

Feb 13, 2024

SELL
$8.77 - $10.85 $70,949 - $87,776
-8,090 Reduced 3.8%
205,063 $2.22 Million
Q3 2023

Nov 14, 2023

SELL
$9.59 - $11.35 $306,927 - $363,256
-32,005 Reduced 13.05%
213,153 $2.1 Million
Q2 2023

Aug 09, 2023

BUY
$9.02 - $10.29 $407,243 - $464,583
45,149 Added 22.57%
245,158 $2.45 Million
Q1 2023

May 15, 2023

BUY
$9.2 - $12.26 $112,948 - $150,516
12,277 Added 6.54%
200,009 $1.92 Million
Q4 2022

Feb 14, 2023

BUY
$8.72 - $11.56 $431,413 - $571,919
49,474 Added 35.78%
187,732 $2.09 Million
Q3 2022

Nov 10, 2022

SELL
$8.48 - $11.13 $980,254 - $1.29 Million
-115,596 Reduced 45.54%
138,258 $1.18 Million
Q2 2022

Aug 11, 2022

SELL
$9.95 - $12.27 $43,899 - $54,135
-4,412 Reduced 1.71%
253,854 $2.66 Million
Q1 2022

May 12, 2022

BUY
$9.81 - $15.4 $294,545 - $462,385
30,025 Added 13.15%
258,266 $2.81 Million
Q4 2021

Feb 14, 2022

BUY
$12.09 - $14.68 $1.37 Million - $1.66 Million
113,414 Added 98.77%
228,241 $3.09 Million
Q3 2021

Nov 16, 2021

BUY
$13.25 - $15.13 $263,714 - $301,132
19,903 Added 20.97%
114,827 $1.56 Million
Q2 2021

Aug 13, 2021

BUY
$12.97 - $16.15 $479,825 - $597,469
36,995 Added 63.86%
94,924 $1.36 Million
Q1 2021

May 17, 2021

BUY
$13.59 - $18.54 $116,303 - $158,665
8,558 Added 17.33%
57,929 $809,000
Q4 2020

Feb 17, 2021

BUY
$14.3 - $18.74 $706,005 - $925,212
49,371 New
49,371 $925,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.